Manufacturing case studies from across the HVM Catapult

Our case studies provide snapshots from the exciting work we’re doing with businesses, researchers, and government across the UK.

Sort by:
Filters
HVM Centres
See more
Regions
See more
Sectors
See more
Technology
See more
Theme
See more
Who We Work With
See more

CASE STUDY

Seismic II takes schools to the next level

Large public works, like schools and hospitals, are increasingly benefitting from the faster delivery of modern methods of construction, such as modular building. The catch is that there are many platforms for modular structures that can prove incompatible, leading to potential waste and increased cost.

3 February 2022

CASE STUDY

Smart, sustainable homes for the future

An estimated 345,000 homes need to be built in the UK each year to meet demand. To reach the Government’s target of net zero by 2050, each of them will need to have impeccable green credentials. Achieving this requires examining radical solutions.

3 February 2022

CASE STUDY

Environmentally friendly solution for wind turbine installation

With funding from the Offshore Wind Growth Partnership, the NCC worked with Cedeco to develop an early-stage concept for a composite gripper, which would hold an offshore wind turbine leg in place without so much need for environmentally invasive reinforcement.

3 February 2022

CASE STUDY

End-to-end hydrogen – supporting critical infrastructure

Hydrogen is a powerful fuel source that has the potential to revolutionise a number of sectors, including transport. With almost zero carbon emissions and a high energy density, this abundant gas promises to be a key element of delivering net zero whilst satisfying the increasing national need for energy.

3 February 2022

Nuclear Advanced Manufacturing Research Centre

CASE STUDY

Creating jobs in nuclear energy

Nuclear is an obvious answer, but lead times are lengthy and the financing challenges for large reactors are formidable.

3 February 2022

CASE STUDY

Pressing ahead with rehab revolution

The AMRC has helped a Sheffield SME transform healthcare by making a rehabilitation innovation 11% lighter and cutting the cost of manufacturing for three components by a combined 73%.

3 February 2022

CASE STUDY

Supporting patients with cerebral palsy

The current standing frames have a number of limitations, including high cost of manufacture, ease of use for medical professionals and carers, and the bespoke nature of each frame making it difficult to re-adapt them for other patients.

3 February 2022

CASE STUDY

Anti-microbial poles for public transport could help in future pandemics

Since the beginning of the COVID-19 pandemic many people have been hesitant about taking public transport. In part, this is due to the potential risk of picking up germs from areas travellers must use, such as the grab-poles on trains, buses and trams.

3 February 2022

CASE STUDY

Helping construction reopen safely

Social distancing is key to reopening sections of the economy that have needed to close during the COVID-19 pandemic. Due to the group nature of the work, social distancing has particularly hit the UK construction sector, meaning many sites have been unable to operate normally.

3 February 2022

Large manufacturing equipment

CASE STUDY

Dental aerosol protection equipment to safeguard against airborne particles

To help address this, the MTC has developed ‘Halo’. Designed to protect dentistry staff and patients against contaminated aerosol particles, it provides up to 99% protection when used in conjunction with standard dental high-volume extraction equipment.

3 February 2022

CASE STUDY

Developing an aerosol-generating procedure shield to protect NHS workers

Identified as an opportunity to reduce the exposure our healthcare workers face when treating patients, the enhancement offers a number of benefits, including a substantial weight reduction from 9kg to 4.5kg, improved visual clarity and ease of use.

3 February 2022

CASE STUDY

Vaccine taskforce

The UK’s vaccine programme has been vital in combatting COVID-19. In April 2020, CPI joined the UK Government’s Vaccine Taskforce to support the manufacture and formulation of novel mRNA vaccine candidates in the fight against the virus.

3 February 2022

Next Page